Chemical Structure (Psma 01)
Gallium Ga-68 Psma-11 Injection, Solution
Product Images NDC 24275-0525
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Gallium Ga-68 Psma-11 (NDC 24275-0525). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ucsf Radiopharmaceutical Facility, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (18.5 MBq/mL Vial Label)
Gallium Ga 68 Gozetotide Injection is a diagnostic solution intended for intravenous use only. Each multiple-dose vial contains a sterile and non-pyrogenic solution with a concentration of 18.5 MBq to 185 MBq (0.5 mCi to 5 mCi) of gallium Ga 68 gozetotide at EOS® with <10% ethanol in 0.9% sodium chloride. The recommended dosage should be calculated from the date and time of calibration as indicated in the prescribing information. This radioactive material should be stored upright in a lead-shielded container at 25°C and not used if it is cloudy or contains particulate matter. The solution expires 4 hours after EOS, and caution should be taken when handling doses. The batch number, EOS date, EOS time, activity at EOS™, concentration, volume, and expiration date must be recorded. The manufacturer is the UCSF Radiopharmaceutical Facility in San Francisco, CA. #Ga Hal.ife = 68 minutes.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
